人工流产后及时使用屈螺酮炔雌醇片的临床价值

The Clinical Value of Early Use of Drospirenone and Ethinylestradiol Tablets After Artificial Abortion

目的研究人工流产后及时使用屈螺酮炔雌醇片的临床价值。方法选择我院2014年12月—2016年10月实行人工流产者1 000例。依据患者手术时间先后分为对照组和观察组。对照组患者常规服用抗生素与五加生化胶囊,观察组在对照组基础上术后开始服用屈螺酮炔雌醇片。对比两组患者临床效果。结果观察组患者1年内重复流产率0.0%(0/500),低于对照组的7.0%(35/500)(P<0.05);比较两组患者正常转经率、宫腔粘连率、阴道流血量与流血时间,观察组具有优势,两组数据差异具有统计学意义(P<0.05)。结论实行人工流产后及时服用避孕药屈螺酮炔雌醇片,可降低重复流产率、宫腔粘连率并缩短患者阴道流血时间。

Objective To study the clinical value of early use of drospirenone and ethinylestradiol tablets after artificial abortion. Methods 1 000 cases of artificial abortion in our hospital were selected, and the time of selection was from December 2014 to October 2016. The patients were divided into control group and observation group according to the operation time. The control group was treated with conventional antibiotics and Wujia Shenghua capsule, the observation group was treated with drospirenone and ethinylestradiol tablets after the operationday based on the treatment of control group. The clinical effects of the two groups were compared. Results The repeated abortion rate within one year in the observation group was 0.0% （0/500）, significantly lower than the control group 7.0% （35/500） （P 〈 0.05）; normal turning rate, the intrauterine adhesion rate, the amount of vaginal bleeding and bleeding time in the observation group had obvious advantages, the difference was statistic significant （P 〈 0.05）. Conclusion The postpartum timely use of drospirenone and ethinylestradiol tablet in artificial abortion, can significantly reduce the repeated abortion rate, reduce the probability of intrauterine adhesions and shorten the time of vaginal bleeding.